137 related articles for article (PubMed ID: 36695252)
1. Lung cancer in Asian Indian females: Identification of disease-specific characteristics and outcome measures over a 12-year period.
Iyer H; Ghosh T; Garg A; Agarwal H; Jain D; Pandey R; Bhalla AS; Kumar R; Vashistha V; Tiwari P; Mittal S; Hadda V; Madan K; Guleria R; Mohan A
Lung India; 2023; 40(1):4-11. PubMed ID: 36695252
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center.
Mohan A; Garg A; Gupta A; Sahu S; Choudhari C; Vashistha V; Ansari A; Pandey R; Bhalla AS; Madan K; Hadda V; Iyer H; Jain D; Kumar R; Mittal S; Tiwari P; Pandey RM; Guleria R
Lung India; 2020; 37(3):190-197. PubMed ID: 32367839
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment of Yunnan in southwestern China: a real-world study.
Lin Y; Chen L; Li R; Liu X; Li Q; Cai J; Du Y; Zhao G; Wang X; Shen Z; Liao Y; Chen Y; Xie L; Zhou Y; Huang Y
Front Oncol; 2023; 13():1156647. PubMed ID: 37881485
[TBL] [Abstract][Full Text] [Related]
4. Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Jain A; Lim C; Gan EM; Ng DZ; Ng QS; Ang MK; Takano A; Chan KS; Tan WM; Kanesvaran R; Toh CK; Loo CM; Hsu AA; Devanand A; Lim CH; Koong HN; Koh T; Fong KW; Yap SP; Kim SW; Chowbay B; Oon L; Lim KH; Lim WT; Tan EH; Tan DS
PLoS One; 2015; 10(5):e0123587. PubMed ID: 25955322
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations.
Zeng Z; Chen HJ; Yan HH; Yang JJ; Zhang XC; Wu YL
Int J Biol Markers; 2013 Sep; 28(3):249-58. PubMed ID: 23873621
[TBL] [Abstract][Full Text] [Related]
6. [Trend analysis and clinicopathological characteristics of 198 young patients with advanced lung adenocarcinoma].
Li YF; Wang Y; Li JL; Hao XZ; Hu XS; Wang HY
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):750-755. PubMed ID: 27784458
[No Abstract] [Full Text] [Related]
7. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. [Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations].
Liao ML; Chen ZW; Zheng Y; Wu CX; Lu S; Yu YF; Jian H; Cheng BJ
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1876-80. PubMed ID: 17923007
[TBL] [Abstract][Full Text] [Related]
10. First report of upfront treatment with Gefitinib in comparison with chemotherapy in advanced non-small cell lung cancer patients from south India: Analysis of 120 patients.
Louis RA; Rajendranath R; Ganesan P; Sagar TG; Krishnamurthy A
Indian J Med Paediatr Oncol; 2012 Jul; 33(3):146-54. PubMed ID: 23248420
[TBL] [Abstract][Full Text] [Related]
11. Lung Cancer in Non-Smokers: Clinicopathological and Survival Differences from Smokers.
Vasudevan S; Krishna V; Mehta A
Cureus; 2022 Dec; 14(12):e32417. PubMed ID: 36644085
[TBL] [Abstract][Full Text] [Related]
12. Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
Barquín M; Calvo V; García-García F; Nuñez B; Sánchez-Herrero E; Serna-Blasco R; Auglytė M; Carcereny E; Rodriguez-Abreu D; López Castro R; Guirado M; Camps C; Bosch-Barrera J; Massuti B; Ortega AL; Del Barco E; Gonzalez-Larriba JL; Aguiar D; García-Campelo R; Dómine M; Agraso S; Sala MA; Oramas J; Bernabé R; Blanco R; Parejo C; Cruz A; Menasalvas E; Royuela A; Romero A; Provencio M
Cancer Epidemiol; 2020 Aug; 67():101737. PubMed ID: 32450544
[TBL] [Abstract][Full Text] [Related]
13. Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
Saw SPL; Zhou S; Chen J; Lai G; Ang MK; Chua K; Kanesvaran R; Ng QS; Jain A; Tan WL; Rajasekaran T; Lim DWT; Tan A; Fong KW; Takano A; Cheng XM; Lim KH; Koh T; Ong BH; Tan EH; Toh CK; Skanderup AJ; Tan SH; Tan DSW
JAMA Netw Open; 2021 Nov; 4(11):e2131892. PubMed ID: 34739062
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting 30-month survival in lung cancer patients.
Mahesh PA; Archana S; Jayaraj BS; Patil S; Chaya SK; Shashidhar HP; Sunitha BS; Prabhakar AK
Indian J Med Res; 2012 Oct; 136(4):614-21. PubMed ID: 23168702
[TBL] [Abstract][Full Text] [Related]
15. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
[TBL] [Abstract][Full Text] [Related]
16. Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018.
Tseng JS; Chiang CJ; Chen KC; Zheng ZR; Yang TY; Lee WC; Hsu KH; Huang YH; Liu TW; Hsia JY; Chang GC
JAMA Netw Open; 2022 Mar; 5(3):e224830. PubMed ID: 35353165
[TBL] [Abstract][Full Text] [Related]
17. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
[TBL] [Abstract][Full Text] [Related]
19. EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital.
Choi YL; Sun JM; Cho J; Rampal S; Han J; Parasuraman B; Guallar E; Lee G; Lee J; Shim YM
PLoS One; 2013; 8(2):e56011. PubMed ID: 23468851
[TBL] [Abstract][Full Text] [Related]
20. [Survival in Lung Cancer among Female Never-smokers in Rural Xuanwei
and Fuyuan Counties in Eastern Yunnan Province, China].
Li J; He J; Zhang Y; Huang Y; Liu S; Li Y; Xu J; He X; Lan Q
Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):477-487. PubMed ID: 31451137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
